{
    "zip": "CB22 3AT",
    "sector": "Healthcare",
    "fullTimeEmployees": 84,
    "longBusinessSummary": "F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing first-in-human clinical study of FS222, a bispecific antibody that is in Phase 1 clinical trial targeting the costimulatory CD137 receptor and the inhibitory PD-L1 ligand. In addition, the company is also evaluating FS120 and SB 11285 for patients with advanced cancers, which are under Phase 1 clinical trials. F-star Therapeutics, Inc. was incorporated in 2002 and is headquartered in Cambridge, the United Kingdom.",
    "city": "Cambridge",
    "phone": "44 1223 497400",
    "country": "United Kingdom",
    "companyOfficers": [],
    "website": "https://www.f-star.com",
    "maxAge": 1,
    "address1": "Eddeva B920",
    "industry": "Biotechnology",
    "address2": "Babraham Research Campus",
    "ebitdaMargins": -1.47459,
    "profitMargins": -1.6170399,
    "grossMargins": 1,
    "operatingCashflow": -24504000,
    "revenueGrowth": -0.125,
    "operatingMargins": -1.50272,
    "ebitda": -30673000,
    "targetLowPrice": 7,
    "recommendationKey": "buy",
    "grossProfits": 21167000,
    "freeCashflow": -13628875,
    "targetMedianPrice": 32,
    "currentPrice": 6.3,
    "earningsGrowth": null,
    "currentRatio": 6.108,
    "returnOnAssets": -0.23238,
    "numberOfAnalystOpinions": 5,
    "targetMeanPrice": 27,
    "debtToEquity": 14.808,
    "returnOnEquity": -0.54691005,
    "targetHighPrice": 35,
    "totalCash": 68801000,
    "totalDebt": 13055000,
    "totalRevenue": 20801000,
    "totalCashPerShare": 3.201,
    "financialCurrency": "USD",
    "revenuePerShare": 1.059,
    "quickRatio": 5.767,
    "recommendationMean": 2.4,
    "exchange": "NCM",
    "shortName": "F-star Therapeutics, Inc.",
    "longName": "F-star Therapeutics, Inc.",
    "exchangeTimezoneName": "America/New_York",
    "exchangeTimezoneShortName": "EDT",
    "isEsgPopulated": false,
    "gmtOffSetMilliseconds": "-14400000",
    "quoteType": "EQUITY",
    "symbol": "FSTX",
    "messageBoardId": "finmb_662294213",
    "market": "us_market",
    "annualHoldingsTurnover": null,
    "enterpriseToRevenue": 1.019,
    "beta3Year": null,
    "enterpriseToEbitda": -0.691,
    "52WeekChange": -0.28164196,
    "morningStarRiskRating": null,
    "forwardEps": -2.32,
    "revenueQuarterlyGrowth": null,
    "sharesOutstanding": 21557800,
    "fundInceptionDate": null,
    "annualReportExpenseRatio": null,
    "totalAssets": null,
    "bookValue": 4.102,
    "sharesShort": 316802,
    "sharesPercentSharesOut": 0.0147,
    "fundFamily": null,
    "lastFiscalYearEnd": 1640908800,
    "heldPercentInstitutions": 0.54832,
    "netIncomeToCommon": -33636000,
    "trailingEps": -1.712,
    "lastDividendValue": null,
    "SandP52WeekChange": -0.091264725,
    "priceToBook": 1.5358361,
    "heldPercentInsiders": 0.042179998,
    "nextFiscalYearEnd": 1703980800,
    "yield": null,
    "mostRecentQuarter": 1648684800,
    "shortRatio": 2.44,
    "sharesShortPreviousMonthDate": 1651190400,
    "floatShares": 21074524,
    "beta": null,
    "enterpriseValue": 21199698,
    "priceHint": 2,
    "threeYearAverageReturn": null,
    "lastSplitDate": null,
    "lastSplitFactor": null,
    "legalType": null,
    "lastDividendDate": null,
    "morningStarOverallRating": null,
    "earningsQuarterlyGrowth": null,
    "priceToSalesTrailing12Months": 6.5292125,
    "dateShortInterest": 1653955200,
    "pegRatio": null,
    "ytdReturn": null,
    "forwardPE": -2.7155175,
    "lastCapGain": null,
    "shortPercentOfFloat": 0.0149,
    "sharesShortPriorMonth": 201151,
    "impliedSharesOutstanding": 0,
    "category": null,
    "fiveYearAverageReturn": null,
    "previousClose": 6.39,
    "regularMarketOpen": 6.4,
    "twoHundredDayAverage": 4.584615,
    "trailingAnnualDividendYield": 0,
    "payoutRatio": 0,
    "volume24Hr": null,
    "regularMarketDayHigh": 6.48,
    "navPrice": null,
    "averageDailyVolume10Day": 1121890,
    "regularMarketPreviousClose": 6.39,
    "fiftyDayAverage": 3.1682,
    "trailingAnnualDividendRate": 0,
    "open": 6.4,
    "toCurrency": null,
    "averageVolume10days": 1121890,
    "expireDate": null,
    "algorithm": null,
    "dividendRate": null,
    "exDividendDate": null,
    "circulatingSupply": null,
    "startDate": null,
    "regularMarketDayLow": 6.24,
    "currency": "USD",
    "regularMarketVolume": 898938,
    "lastMarket": null,
    "maxSupply": null,
    "openInterest": null,
    "marketCap": 135814144,
    "volumeAllCurrencies": null,
    "strikePrice": null,
    "averageVolume": 289601,
    "dayLow": 6.24,
    "ask": 0,
    "askSize": 1800,
    "volume": 898938,
    "fiftyTwoWeekHigh": 9.3,
    "fromCurrency": null,
    "fiveYearAvgDividendYield": null,
    "fiftyTwoWeekLow": 2.07,
    "bid": 0,
    "tradeable": false,
    "dividendYield": null,
    "bidSize": 900,
    "dayHigh": 6.48,
    "regularMarketPrice": 6.3,
    "preMarketPrice": null,
    "logo_url": "https://logo.clearbit.com/f-star.com"
}